Pancreatic Cancer Research

ResearcherQinghai Red Cross HospitalActive in the last 2 years

Junlin Gao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-4103-2649; OpenAlex author ID A5021791616. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
3
Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

  1. Reporting Odds Ratio Analysis of Gemcitabine-Based Chemotherapy Regimens for Biliary and Pancreatic Cancer: Population-Level Toxicity Signals and Hypotheses fo… Last author DOI 10.64898/2026.09.24.26363686↗
  2. Knockdown of TGF-β in Pancreatic Cancer Helps Ameliorate Gemcitabine Resistance. Last author DOI 10.31083/j.fbl2907269↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhongfeng Dang · 1 shared paper, 2026 · strength 0.25
  2. Zhenhai Zhang · 1 shared paper, 2024 · strength 0.23
  3. Xinxing Wang · 1 shared paper, 2024 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.